GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (OTCPK:HLBBF) » Definitions » Equity-to-Asset

H. Lundbeck AS (H. Lundbeck AS) Equity-to-Asset : 0.59 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. H. Lundbeck AS's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $3,271 Mil. H. Lundbeck AS's Total Assets for the quarter that ended in Mar. 2024 was $5,518 Mil. Therefore, H. Lundbeck AS's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.59.

The historical rank and industry rank for H. Lundbeck AS's Equity-to-Asset or its related term are showing as below:

HLBBF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.4   Med: 0.53   Max: 0.62
Current: 0.59

During the past 13 years, the highest Equity to Asset Ratio of H. Lundbeck AS was 0.62. The lowest was 0.40. And the median was 0.53.

HLBBF's Equity-to-Asset is ranked better than
52.12% of 1086 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs HLBBF: 0.59

H. Lundbeck AS Equity-to-Asset Historical Data

The historical data trend for H. Lundbeck AS's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H. Lundbeck AS Equity-to-Asset Chart

H. Lundbeck AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.47 0.53 0.56 0.59

H. Lundbeck AS Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 0.58 0.59 0.59 0.59

Competitive Comparison of H. Lundbeck AS's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, H. Lundbeck AS's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


H. Lundbeck AS's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, H. Lundbeck AS's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where H. Lundbeck AS's Equity-to-Asset falls into.



H. Lundbeck AS Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

H. Lundbeck AS's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=3225.405/5473.02
=0.59

H. Lundbeck AS's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=3270.504/5517.945
=0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


H. Lundbeck AS  (OTCPK:HLBBF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


H. Lundbeck AS Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of H. Lundbeck AS's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


H. Lundbeck AS (H. Lundbeck AS) Business Description

Address
Ottiliavej 9, Valby, DNK, 2500
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system, or CNS, drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.